Time-sensitive reversal of hyperplasia in transgenic mice expressing SV40 T antigen

被引:197
|
作者
Ewald, D
Li, MG
Efrat, S
Auer, G
Wall, RJ
Furth, PA
Hennighausen, L
机构
[1] UNIV MARYLAND,SCH MED,DEPT MED,DIV INFECT DIS,BALTIMORE,MD 21201
[2] INST HUMAN VIROL,BALTIMORE,MD 21201
[3] ALBERT EINSTEIN COLL MED,DEPT MOL PHARMACOL,BRONX,NY 10461
[4] KAROLINSKA INST,DEPT PATHOL & ONCOL,S-17176 STOCKHOLM,SWEDEN
[5] ARS,USDA,BELTSVILLE,MD 20705
[6] NIDDKD,BIOCHEM & METAB LAB,NIH,BETHESDA,MD 20892
基金
英国自然环境研究理事会; 英国生物技术与生命科学研究理事会;
关键词
D O I
10.1126/science.273.5280.1384
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The role of viral oncoprotein expression in the maintenance of cellular transformation was examined as a function of time through controlled expression of simian virus 40 T antigen (TAg), Expression of TAg in the submandibular gland of transgenic mice from the time of birth induced cellular transformation and extensive ductal hyperplasia by 4 months of age, The hyperplasia was reversed when TAg expression was silenced for 3 weeks, When TAg expression was silenced after 7 months, however, the hyperplasia persisted even though TAg was absent, Although the polyploidy of ductal cells could be reversed at 4 months of age, cells at 7 months of age remained polyploid even in the absence of TAg, These results support a model of time-dependent multistep tumorigenesis, in which virally transformed cells eventually lose their dependence on the viral oncoprotein for maintenance of the transformed state.
引用
收藏
页码:1384 / 1386
页数:3
相关论文
共 50 条
  • [1] Development of thymic carcinoma in transgenic mice expressing SV40 T antigen
    Park, WY
    Kim, JI
    Shim, EH
    Lee, WH
    Kim, SH
    Seo, JW
    Jang, JJ
    Seo, JS
    CANCER LETTERS, 1996, 107 (02) : 293 - 300
  • [2] SV40 T-ANTIGEN IS A HISTOCOMPATIBILITY ANTIGEN OF SV40-TRANSGENIC MICE
    WETTSTEIN, PJ
    JEWETT, L
    FAAS, S
    BRINSTER, RL
    KNOWLES, BB
    IMMUNOGENETICS, 1988, 27 (06) : 436 - 441
  • [3] CHRONIC THROMBOCYTOPENIA IN TRANSGENIC MICE EXPRESSING MEGAKARYOCYTE TARGETED SV40 T-ANTIGEN
    ROBINSON, MO
    ZHOU, W
    HOKOM, M
    DANELINKO, D
    HUNT, P
    BOSSELMAN, R
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 235 - 235
  • [4] HYPOMYELINATING PERIPHERAL NEUROPATHIES AND SCHWANNOMAS IN TRANSGENIC MICE EXPRESSING SV40 T-ANTIGEN
    MESSING, A
    BEHRINGER, RR
    WRABETZ, L
    HAMMANG, JP
    LEMKE, G
    PALMITER, RD
    BRINSTER, RL
    JOURNAL OF NEUROSCIENCE, 1994, 14 (06): : 3533 - 3539
  • [5] Alterations of the thymic selection process in transgenic mice expressing SV40 large T antigen
    Lee, WH
    Seo, JS
    INTERNATIONAL JOURNAL OF CANCER, 1996, 67 (03) : 399 - 404
  • [6] SV40 T-ANTIGEN ACTS AS A MINOR HISTOCOMPATIBILITY ANTIGEN OF SV40 T-ANTIGEN TOLERANT TRANSGENIC MICE
    JURETIC, A
    KNOWLES, BB
    IMMUNOGENETICS, 1989, 29 (06) : 366 - 370
  • [7] SV40 TRANSGENIC MICE THAT DEVELOP TUMORS ARE IMMUNOLOGICALLY TOLERANT TO SV40 T-ANTIGEN
    FAAS, SJ
    PAN, S
    PINKERT, CA
    BRINSTER, RL
    KNOWLES, BB
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1986, : 56 - 56
  • [8] Trilateral tumors in four different lines of transgenic mice expressing SV40 T-antigen
    Marcus, DM
    Lasudry, JGH
    Carpenter, JL
    Windle, J
    Howes, KA
    AlUbaidi, MR
    Baehr, W
    Overbeek, PA
    Font, RL
    Albert, DM
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1996, 37 (02) : 392 - 396
  • [9] SMOOTH-MUSCLE AND BONE NEOPLASMS IN TRANSGENIC MICE EXPRESSING SV40 T-ANTIGEN
    WILKIE, TM
    SCHMIDT, RA
    BAETSCHER, M
    MESSING, A
    ONCOGENE, 1994, 9 (10) : 2889 - 2895
  • [10] SV40 T-ANTIGEN DISRUPTS MEGAKARYOCYTE DIFFERENTIATION IN TRANSGENIC MICE
    ROBINSON, MO
    ZHOU, W
    HOKOM, M
    DANELINKO, D
    HUNT, P
    BOSSELMAN, R
    EXPERIMENTAL HEMATOLOGY, 1993, 21 (08) : 1028 - 1028